Deutsche Bank
SQZ

Deutsche Bank’s SQZ Biotechnologies Company SQZ Stock Holding History

Deutsche Bank’s Portfolio SQZ Stock Details SQZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,357
Closed -$59K – 4408
2022
Q1 		$59K Sell
12,357
-28,112
-69% -$178K ﹤0.01% 3787
2021
Q4 		$361K Sell
40,469
-41,904
-51% -$514K ﹤0.01% 3034
2021
Q3 		$1.19M Sell
82,373
-418
-0.5% -$5.67K ﹤0.01% 2502
2021
Q2 		$1.2M Buy
82,791
+79,943
+2,807% +$1.04M ﹤0.01% 2663
2021
Q1 		$39K Sell
2,848
-276
-9% -$5.61K ﹤0.01% 4291
2020
Q4 		$91K Buy
+3,124
New +$79.7K ﹤0.01% 3891

Other funds holding SQZ

Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
AIG
American International Group New York $609M AUM 23.67% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Deutsche Bank's SQZ Position: Q2 2022 in Review

Deutsche Bank sold out of SQZ Biotechnologies Company (SQZ) in Q2 2022, closing a stake of 12,357 shares — an estimated $59K sold.

Deutsche Bank first reported a position in SQZ in Q4 2020 and held it in 6 quarters. The position peaked at $1.2M in Q2 2021. 53 funds tracked by Wall St. Rank hold SQZ as of Q2 2022.

  • Deutsche Bank reported no remaining SQZ Biotechnologies Company position as of Q2 2022 after selling out during the quarter.
  • Deutsche Bank sold 12,357 SQZ Biotechnologies Company shares in Q2 2022, an estimated $59K.
  • Deutsche Bank first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 6 quarters.
  • Deutsche Bank's SQZ Biotechnologies Company position peaked at $1.2M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.